hypericin
Trade name: sgx301
Small moleculeexperimental
Hypericin is a carbopolycyclic compound derived from bisanthene with antidepressant properties, found in various Hypericum species, and is being studied for treating cutaneous T-cell lymphoma. — Wikipedia
Clinical trial activity
9 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
7
Phase 3
3
Phase 4
0
Earliest trial started Nov 2, 1999 (NCT00000645)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65- Mol. weight
- 504.45 g/mol
- Lipinski Ro5
- 3 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaHypericin ↗
- ChEMBLCHEMBL286494 ↗
Also known as
- 1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro(1,10,9,8-opqra)perylene-7,14-dione
- hipericin
- hypericin
- hypericin
- hypericin
- hypericin
- mono-(123i)iodohypericin
- sgx301
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06470451 | Phase 3 | Oct 31, 2024 | Soligenix |
| NCT06149247 | Phase 2 | Dec 5, 2023 | Soligenix |
| NCT05872854 | Phase 2 | Aug 21, 2023 | Soligenix, University of Pennsylvania |
| NCT05442190 | Phase 2 | Dec 14, 2022 | Soligenix |
| NCT05380635 | Phase 2 | May 9, 2022 | Soligenix |
| NCT02448381 | Phase 3 | Dec 1, 2015 | Soligenix |
| NCT01365676 | Phase 3 | Mar 1, 2012 | Federal University of Health Science of Porto Alegre, Phytopharm |
| NCT00000645 | Phase 1 | Nov 2, 1999 | National Institute of Allergy and Infectious Diseases (NIAID), Nexell Therapeutics |
| NCT00000792 | Phase 1 | Nov 2, 1999 | National Institute of Allergy and Infectious Diseases (NIAID), Nexell Therapeutics |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Soligenix | For profit | 6 | 5 | 2 | 2015 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 1 | 1999 |
| Nexell Therapeutics | For profit | 2 | 0 | 1 | 1999 |
| Federal University of Health Science of Porto Alegre | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Phytopharm | For profit | 1 | 1 | 1 | 2012 |
| University of Pennsylvania | Academic/Hospital | 1 | 1 | 1 | 2023 |
6 organizations
Page 1 / 1